INmune Bio(INMB) - 2021 Q2 - Earnings Call Transcript

INmune Bio, Inc. (NASDAQ:INMB) Q2 2021 Results Conference Call August 4, 2021 4:30 PM ET Company Participants David Moss - Co-Founder and CFO Dr. RJ Tesi - CEO and Co-Founder Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Mikhail Keyserman - BTIG Mayank Mamtani - B. Riley Securities Mark Lowdell - Chief Scientific Officer and Chief Manufacturing Officer Daniel Carlson - TW Research Operator Greetings, and welcome to the INmune Bio Second Quarter 2021 Earnings Call. [Operator Instructi ...